Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO
Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO of Photonify served ADAC as a senior vice president, as well as general manager of the PET division and vice president of marketing. Before that, Elmandjra worked eight years at GE Medical Systems, where he held various management positions in Europe and the U.S. Elmandjra will also serve on the board of directors for privately held Photonify, which is developing an optical spectroscopy product that may allow quantitative real-time imaging and oxygen mapping.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.